Are you Dr. Sharma?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 88 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Padmanee Sharma, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Florida, and Oklahoma. She is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor at Division of Cancer Medicine.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2004
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2000
Pennsylvania State University College of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2004 - 2024
OK State Medical License 2020 - 2021
NY State Medical License 1999 - 2005
Clinical Trials
- NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine Start of enrollment: 2004 Sep 27
- Neoadjuvant Ipilimumab in Prostate Cancer Start of enrollment: 2010 Sep 01
- Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer Start of enrollment: 2014 Apr 22
- Join now to see all
Publications & Presentations
PubMed
- ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype.Naveen Sharma, Xiaozhou Fan, Oluwatomisin T Atolagbe, Zhongqi Ge, Kelly N Dao, James P Allison, Padmanee Sharma> ;The Journal of Experimental Medicine. 2024 Apr 1
- Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer.Sreyashi Basu, Sonali Jindal, Zhong He, Khoi Chu, Akshara Singareeka Raghavendra, Haven R Garber, Clinton Yam, Lumarie Santiago, Beatriz E Adrada, Padmanee Sharma, Eli...> ;Oncotarget. 2024 Mar 19
- Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032).Margaret Callahan, Asim Amin, Frederic J Kaye, Michael A Morse, Matthew H Taylor, Katriina J Peltola, Padmanee Sharma, Eileen M O'Reilly, Stephanie Meadows Shropshire,...> ;Journal for Immunotherapy of Cancer. 2024 Feb 5
- Join now to see all
Press Mentions
Allison Institute Announces Appointment of Inaugural MembersMay 10th, 2023- Carisma Therapeutics Appoints Leading Solid Tumor Immunotherapy Expert Padmanee Sharma, MD, PhD to Scientific Advisory BoardJanuary 31st, 2023
- Allison Institute Announces Formation of Scientific Advisory BoardAugust 15th, 2022
- Join now to see all
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
